RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis
Authors
Keywords
-
Journal
NATURE
Volume 513, Issue 7516, Pages 90-94
Publisher
Springer Nature
Online
2014-08-15
DOI
10.1038/nature13608
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Loss of Epithelial RelA Results in Deregulated Intestinal Proliferative/Apoptotic Homeostasis and Susceptibility to Inflammation
- (2014) K. A. Steinbrecher et al. JOURNAL OF IMMUNOLOGY
- Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
- (2014) Yanfang Fu et al. NATURE BIOTECHNOLOGY
- Regulated necrosis: the expanding network of non-apoptotic cell death pathways
- (2014) Tom Vanden Berghe et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Control of Life-or-Death Decisions by RIP1 Kinase
- (2013) Dana E Christofferson et al. Annual Review of Physiology
- Tumor Necrosis Factor Receptor Signaling in Keratinocytes Triggers Interleukin-24-Dependent Psoriasis-like Skin Inflammation in Mice
- (2013) Snehlata Kumari et al. IMMUNITY
- A T-bet gradient controls the fate and function of CCR6−RORγt+ innate lymphoid cells
- (2013) Christoph S. N. Klose et al. NATURE
- Survival Function of the FADD-CASPASE-8-cFLIPL Complex
- (2012) Christopher P. Dillon et al. Cell Reports
- The Adaptor Protein FADD Protects Epidermal Keratinocytes from Necroptosis In Vivo and Prevents Skin Inflammation
- (2011) Marion C. Bonnet et al. IMMUNITY
- RIP Kinase-Dependent Necrosis Drives Lethal Systemic Inflammatory Response Syndrome
- (2011) Linde Duprez et al. IMMUNITY
- RIG-I RNA Helicase Activation of IRF3 Transcription Factor Is Negatively Regulated by Caspase-8-Mediated Cleavage of the RIP1 Protein
- (2011) Akhil Rajput et al. IMMUNITY
- Tumor Necrosis Factor Receptor-associated Factor (TRAF) 2 Controls Homeostasis of the Colon to Prevent Spontaneous Development of Murine Inflammatory Bowel Disease
- (2011) Jiang-Hu Piao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- In TNF-stimulated Cells, RIPK1 Promotes Cell Survival by Stabilizing TRAF2 and cIAP1, which Limits Induction of Non-canonical NF-κB and Activation of Caspase-8
- (2011) Ian E. Gentle et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TNF -induced noncanonical NF- B activation is attenuated by RIP1 through stabilization of TRAF2
- (2011) J.-Y. Kim et al. JOURNAL OF CELL SCIENCE
- Constitutive IKK2 activation in intestinal epithelial cells induces intestinal tumors in mice
- (2011) Katerina Vlantis et al. JOURNAL OF CLINICAL INVESTIGATION
- FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation
- (2011) Patrick-Simon Welz et al. NATURE
- RIP3 mediates the embryonic lethality of caspase-8-deficient mice
- (2011) William J. Kaiser et al. NATURE
- Catalytic activity of the caspase-8–FLIPL complex inhibits RIPK3-dependent necrosis
- (2011) Andrew Oberst et al. NATURE
- Functional complementation between FADD and RIP1 in embryos and lymphocytes
- (2011) Haibing Zhang et al. NATURE
- Slide preparation for single-cell–resolution imaging of fluorescent proteins in their three-dimensional near-native environment
- (2011) Hugo J Snippert et al. Nature Protocols
- Intestinal Bacteria and the Regulation of Immune Cell Homeostasis
- (2010) David A. Hill et al. Annual Review of Immunology
- Inflammatory Bowel Disease
- (2010) Arthur Kaser et al. Annual Review of Immunology
- Virus Inhibition of RIP3-Dependent Necrosis
- (2010) Jason W. Upton et al. Cell Host & Microbe
- Oligodendrocyte-Specific FADD Deletion Protects Mice from Autoimmune-Mediated Demyelination
- (2010) C. Mc Guire et al. JOURNAL OF IMMUNOLOGY
- Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
- (2009) Toshiro Sato et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started